Review article: Gastric atrophy and atrophic gastritis - Nebulous concepts in search of a definition

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue SUPPL. 1, 1998, Pages 17-23

  Genta, R M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHIC GASTRITIS; ATROPHY; CANCER RISK; CONFERENCE PAPER; DISEASE CLASSIFICATION; EPIDEMIOLOGY; HISTOPATHOLOGY; HUMAN; NOMENCLATURE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH MUCOSA LESION;

ADENOCARCINOMA; ATROPHY; GASTRIC MUCOSA; GASTRITIS; HUMANS; OBSERVER VARIATION; PAIN MEASUREMENT; STOMACH NEOPLASMS; TERMINOLOGY;

EID: 0031905019     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1998.00003.x     Document Type: Review

References (37)

1. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996; 214: (Suppl.) 40-3.
2. Parsonnet J, Friedman G D, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
3. Blaser M J, Parsonnet J. Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8.
4. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19 (Suppl. 1):S37-43.
5. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994; 6 (Suppl. 1): S79-83.
6. Genta R M. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996; 20 (Suppl. 1): S23-30.
7. Price A B. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-222.
8. Dixon M F, Genta R M, Yardley J H, et al. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
9. El-Zimaity H M T, Graham D Y, Al Assi M T, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 35-41.
10. Andrew A, Wyatt J I, Dixon M F. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994; 25: 317-22.
11. Sipponen P, Hyvärinen H, Siurala M. H. pylori corpus gastritis - relation to acid output. J Physiol Pharmacol 1996; 47: 151-9.
12. Calam J. The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med 1995; 27: 569-73.
13. el-Omar E M, Penman I D, Ardill J E, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-91.
14. Correa P, Miller M J. Helicobacter pylori and gastric atrophy - cancer paradoxes. J Natl Cancer Inst 1995; 87: 1731-2.
15. Genta R M, Segura A M. Will curing Helicobacter pylori eliminate gastric cancer? Adv Anat Pathol 1996; 3: 228-32.
16. Genta R M. Helicobacter pylori infection in gastric pathology. In: Weinstein R S, ed. Advances in Pathology and Laboratory Medicine, vol 7. Mosby-Year Book. Inc., St. Louis, 1994: 443-65.
17. Smoot D T, Resau J H, Naab T, et al. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect Immun 1993; 61: 350-5.
18. Dytoc M, Gold B, Louie M, et al. Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect Immun 1993; 61: 448-56.
19. Fiocca R, Luinetti O, Villani, et al. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol 1994; 205 (Suppl.): 11-21.
20. Chen X G, Correa P, Offehaus J, et al. Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol 1986; 86: 575-82.
21. Genta R M, Graham D Y. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc 1994; 40: 342-5.
22. Satoh K, Kimura K, Sipponen P. Helicobacter pylori infection and chronological extension of atrophic gastritis. Eur J Gastroenterol Hepatol 1995; 7 (Suppl. 1): S11-5.
23. Villako K, Kekki M, Maaroos H I, et al. A 12-year follow-up study of chronic gastritis and Helicobacter pylori in a population-based random sample. Scand J Gastroenterol 1995; 30: 964-7.
24. Mooney C, Keenan J, Munster D, et al. Neutrophil activation of Helicobacter pylori. Gut 1991; 32: 853-7.
25. Fan X G, Chua A, Fan X J, Keeling P W. Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol 1995; 48: 133-6.
26. Sharma S A, Tummuru M K, Miller G G, Blaser M J. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vivo.Infect Immun 1995; 63: 1681-7.
27. Karttunen R, Karttunen T, Ekre H P, MacDonald T T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995; 36: 341-5.
28. Crabtree J E, Shallcross T M, Heatley R V, Wyatt J I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
29. Mai U E, Perez-Perez G I, Allen J B, Wahl S M, Blaser M J, Smith P D. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992; 175: 517-25.
30. Mannick E E, Bravo L E, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56: 3238-43.
31. Moss S F, Calam J, Agarwal B, Wang S, Holt P R. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
32. Fontham E T, Ruiz B, Perez A, Hunter F, Correa P. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995; 90: 1094-1101.
33. Ruiz B, Correa P, Fontham E T, et al. Ascorbic acid, Helicobacter pylori and Lewis phenotype among blacks and whites in New Orleans. Cancer Lett 1994; 83: 323-9.
34. Blaser M J. Intrastrain differences in Helicobacter pylori: a key question in mucosal damage? Ann Med 1995; 27: 559-63.
35. Chen V W, Abu-Elyazeed R R, Zavala D E, et al. Risk factors of gastric precancerous lesions in a high-risk Colombian population: 1. Salt Nutr Cancer 1990; 13: 59-65.
36. Riddell R H, Goldman H, Ransohoff D F, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
37. Levine D S, Surawicz C M, Ajer T N, Dean P J, Rubin C E. Diffuse excess mucosal collagen in rectal biopsies facilitates differential diagnosis of solitary rectal ulcer syndrome from other inflammatory bowel diseases. Dig Dis Sci 1988; 33: 1345-52.